滚动资讯
Endpoints NewsInhibrx says combo therapy shrank more tumors than Merck's Keytruda aloneFierceBiotechAmid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase dataFierceBiotechDaiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year planFDA News ReleasesFDA Advances Drug Repurposing to Address Unmet Medical NeedsEndpoints NewsBraveheart Bio's Hengrui-licensed cardiac drug scores second clinical winBioPharma DiveBiotech layoffs are easing, but is the worst over?FierceBiotechNovo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotechBioWorldShanghai Jeyou Pharmaceutical patents LGALS3 inhibitorsBioWorldBoyuan Pharmaceutical prepares new HSV inhibitorsBioWorldAntimicrobial compounds revealed in University of Hong Kong patentBioWorldYantai Rongchang Pharmaceutical reports new KRAS mutant inhibitorsBioWorldIn vivo mRNA gene therapy platform reprograms cytotoxic T cells

资讯库

最新 最旧
总数 10728
页码 209 / 596
搜索 --